Pharming Group N.V.

NASDAQ: PHAR · Real-Time Price · USD
12.74
1.09 (9.36%)
At close: Aug 18, 2025, 2:45 PM

Pharming Balance Sheet Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
54.94M 61.74M 207.34M 191.72M
Short-Term Investments
112.95M 151.68M n/a n/a
Long-Term Investments
4.23M 10.4M 9.73M 9.95M
Other Long-Term Assets
1.59M 1.62M 1.33M -303.43K
Receivables
50.17M 42.62M 19.58M 15.88M
Inventory
55.72M 51.41M 42.33M 27.28M
Other Current Assets
8.34M 6.53M 213K 227K
Total Current Assets
278.44M 316.34M 277.5M 249.18M
Property-Plant & Equipment
23.3M 33.47M 39.15M 33.13M
Goodwill & Intangibles
61.04M 71.27M 75.12M 83.75M
Total Long-Term Assets
121.55M 146.51M 148.3M 147.72M
Total Assets
399.99M 462.85M 425.8M 396.9M
Account Payables
10.1M 16.02M 6.08M 5.14M
Deferred Revenue
n/a n/a -56.23K -44.35K
Short-Term Debt
4.1M 1.82M 1.77M 2.42K
Other Current Liabilities
n/a 7.74M 1.61M 2.71M
Total Current Liabilities
73.8M 77.97M 59.7M 46.72M
Long-Term Debt
75.44M 136.6M 122.92M 122.13M
Other Long-Term Liabilities
n/a 2.00 8.7M 17.04M
Total Long-Term Liabilities
105.12M 166.1M 161.46M 157.46M
Total Liabilities
178.92M 244.07M 221.16M 204.19M
Total Debt
108.42M 171.54M 166.69M 161.59M
Common Stock
7.77M 7.67M 7.51M 7.27M
Retained Earnings
-275.49M -265.26M -256.43M -269.45M
Comprehensive Income
-209K -1.86M -8.74M 2.17M
Shareholders Equity
221.06M 218.78M 204.64M 192.72M
Total Investments
117.18M 162.08M 9.73M 9.95M